Skip to main content
Toggle navigation
Login
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yamaguchi, Daichi
Shionogi & Co., Ltd.
(
S-036
)
Modeling for prediction of CCR8 receptor occupancy in human tumor tissues after dosing of S-531011, a humanized anti-CCR8 monoclonal antibody
Daichi Yamaguchi
Favorite
Yamamoto, Shotaro
Nagoya University
(
T-048
)
Modeling clinical trial design in infectious disease outbreaks considering differences in IC50 between in vitro and in vivo
Shotaro Yamamoto
Favorite
Yanamandala, Nitheesh
University at Buffalo
(
T-110
)
PK/PD Modeling of Dexamethasone in Heart and Lung Tissues in an Animal Model of Cytokine Release Syndrome
Nitheesh Yanamandala
Favorite
Yan, Diqin
Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN
(
M-087
)
An Integrated PK-PD Model to Characterize Circadian-Driven ACTH-Cortisol Interactions in Patients with Congenital Adrenal Hyperplasia
Diqin Yan
Favorite
Yang, Tae Eun
Johnson & Johnson Innovative Medicine
(
M-052
)
Exposure-Response Analysis of Guselkumab in Participants with Moderate to Severe Crohn’s Disease
Tae Eun Yang
Favorite
Yang, Xinxin
Bristol Myers Squibb
(
S-065
)
Performance Verification and Application of Endogenous Biomarker Coproporphyrin I in the Simcyp™ Simulator V23
Xinxin Yang
Favorite
Yan, Xiaoyu
The Chinese University of Hong Kong
(
S-040
)
Time-to-event analysis of iron homeostasis to inform survival in cancer patients
Xiaoyu Yan
Favorite
Yin, Xuefen
Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, USA
(
S-069
)
Evaluation and Mitigation of Time-Dependent Confounding Effects in Conventional Exposure-Response Analyses for Small-Molecule Oncology Drugs
Xuefen Yin
Favorite
Yuan, Dongfen
Johnson and Johnson
(
S-005
)
Amivantamab population pharmacokinetics analyses of PALOMA studies supporting the bridging from intravenous formulation to subcutaneous formulation in epidermal growth factor receptor-mutated non-small cell lung cancer
Dongfen Yuan
Favorite
Yuan, Lin
Fractal Therapeutics
(
S-009
)
A novel approach for predicting the efficacy of updated vaccines when the correlate of protection is known
Lin Yuan
Favorite
(
S-010
)
Bayesian modeling allows early inference of pharmacokinetic/pharmacodynamic relationship for a novel small molecule STING agonist in Phase I
Lin Yuan
Favorite
(
S-011
)
Using translational in vitro-in vivo modeling to improve inhaled drug repurposing outcomes for COVID-19
Lin Yuan
Favorite
(
S-116
)
A Novel Bayesian Adaptive Design for Phase I Dose Escalation with Improved Efficiency and Accuracy in Estimation of Maximum Tolerated Dose
Lin Yuan
Favorite
Yu, Yifan
University at Buffalo
(
T-017
)
Multi-Objective Optimization for Population Pharmacokinetic Model Selection: Evaluating Non-dominated Sorting Genetic Algorithm III Performance
Yifan Yu
Favorite
